Loading…

Amyloid β serves as an NGF-like neurotrophic factor or acts as a NGF antagonist depending on its concentration

In the nervous system, both the shape and connectivity of neurons are strongly influenced by soluble, extracellular factors. Indeed, we recently demonstrated that after binding to p75NTR, the common neurotrophin receptor, nerve growth factor (NGF) controls the morphology and connectivity of cultured...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurochemistry 2009-12, Vol.111 (6), p.1425-1433
Main Authors: Arevalo, Maria-Ángeles, Roldan, Pedro M, Chacón, Pedro J, Rodríguez-Tebar, Alfredo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4222-70f34470c0166a98dc58189dbffc9997dc7a88af3d50f9cff21734d39535f2e33
cites cdi_FETCH-LOGICAL-c4222-70f34470c0166a98dc58189dbffc9997dc7a88af3d50f9cff21734d39535f2e33
container_end_page 1433
container_issue 6
container_start_page 1425
container_title Journal of neurochemistry
container_volume 111
creator Arevalo, Maria-Ángeles
Roldan, Pedro M
Chacón, Pedro J
Rodríguez-Tebar, Alfredo
description In the nervous system, both the shape and connectivity of neurons are strongly influenced by soluble, extracellular factors. Indeed, we recently demonstrated that after binding to p75NTR, the common neurotrophin receptor, nerve growth factor (NGF) controls the morphology and connectivity of cultured mouse hippocampal neurons by encouraging the production of fewer yet longer dendrites, and by augmenting GABAergic connectivity. These effects of NGF are mediated by the differential expression of Enhancer-of-split 1/5 homologs and neurogenin 3. Amyloid β (Aβ), a pathogenic agent in Alzheimer's disease (AD) is known to bind to p75NTR, hence we studied its influence on cultured hippocampal neurons. At 800 nM, Aβ(1-40) prevents NGF-induced activation of NF-κB and consequently, it depresses the expression of Enhancer-of-split 1. Thus, at this concentration, the effect of Aβ on neurons is antagonistic to those provoked by NGF and accordingly, neurons sprout more yet shorter dendrites and their GABAergic input decreases. In contrast, at lower concentration, 20 nM, the amyloid induces cellular effects similar to those induced by NGF, both in terms of gene expression, neuronal morphology, and GABAergic connectivity. Our results demonstrate that Aβ may act as a neurotrophic factor that mimics the activity of NGF. However, at higher concentrations, the amyloid behaves as an antagonist of NGF, contributing to the advent of AD.
doi_str_mv 10.1111/j.1471-4159.2009.06412.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734220455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734220455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4222-70f34470c0166a98dc58189dbffc9997dc7a88af3d50f9cff21734d39535f2e33</originalsourceid><addsrcrecordid>eNqNkMtuEzEUhi0EoqHwCuANYjXD8WUy9oJFFdHSqioL6NpyfQkOEzvYE2heiwfhmfAwoWyxjuQj-ft8jn6EMIGW1PN20xLek4aTTrYUQLaw5IS294_Q4uHhMVoAUNow4PQEPStlA0CWfEmeopPqdECFXKB0tj0MKVj86ycuLn93BetaEd9cnDdD-OpwdPucxpx2X4LBXpsxZVyrNjM6kVUY9TrFUEZs3c5FG-Iap4hDhUyKxsUx6zGk-Bw98Xoo7sXxPkW35-8_rz401x8vLldn143htC7dg2ec92DqyksthTWdIELaO--NlLK3ptdCaM9sB14a7ynpGbdMdqzz1DF2it7M_-5y-rZ3ZVTbUIwbBh1d2hdVaUqBd10lxUyanErJzqtdDludD4qAmtJWGzWFqqZQ1ZS2-pO2uq_qy-OQ_d3W2Qfxb7wVeH0EdDF68FlHE8o_jhLBKROVezdzP8LgDv-9gLq6WU1d9V_NvtdJ6XWuM24_USAMSA89E5T9BtrDpCk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734220455</pqid></control><display><type>article</type><title>Amyloid β serves as an NGF-like neurotrophic factor or acts as a NGF antagonist depending on its concentration</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Arevalo, Maria-Ángeles ; Roldan, Pedro M ; Chacón, Pedro J ; Rodríguez-Tebar, Alfredo</creator><creatorcontrib>Arevalo, Maria-Ángeles ; Roldan, Pedro M ; Chacón, Pedro J ; Rodríguez-Tebar, Alfredo</creatorcontrib><description>In the nervous system, both the shape and connectivity of neurons are strongly influenced by soluble, extracellular factors. Indeed, we recently demonstrated that after binding to p75NTR, the common neurotrophin receptor, nerve growth factor (NGF) controls the morphology and connectivity of cultured mouse hippocampal neurons by encouraging the production of fewer yet longer dendrites, and by augmenting GABAergic connectivity. These effects of NGF are mediated by the differential expression of Enhancer-of-split 1/5 homologs and neurogenin 3. Amyloid β (Aβ), a pathogenic agent in Alzheimer's disease (AD) is known to bind to p75NTR, hence we studied its influence on cultured hippocampal neurons. At 800 nM, Aβ(1-40) prevents NGF-induced activation of NF-κB and consequently, it depresses the expression of Enhancer-of-split 1. Thus, at this concentration, the effect of Aβ on neurons is antagonistic to those provoked by NGF and accordingly, neurons sprout more yet shorter dendrites and their GABAergic input decreases. In contrast, at lower concentration, 20 nM, the amyloid induces cellular effects similar to those induced by NGF, both in terms of gene expression, neuronal morphology, and GABAergic connectivity. Our results demonstrate that Aβ may act as a neurotrophic factor that mimics the activity of NGF. However, at higher concentrations, the amyloid behaves as an antagonist of NGF, contributing to the advent of AD.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1111/j.1471-4159.2009.06412.x</identifier><identifier>PMID: 20050289</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford, UK: Oxford, UK : Blackwell Publishing Ltd</publisher><subject>Adult and adolescent clinical studies ; amyloid ; Amyloid beta-Peptides - pharmacology ; Amyloid β ; Animals ; Biological and medical sciences ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; dendrite morphology ; Dendrites - drug effects ; Dendrites - metabolism ; Dose-Response Relationship, Drug ; Embryo, Mammalian ; Enhancer-of-split ; Enzyme-Linked Immunosorbent Assay - methods ; GABAergic synapses ; Gene Expression Regulation - drug effects ; Green Fluorescent Proteins - genetics ; Hippocampus - cytology ; I-kappa B Proteins - metabolism ; Immunoprecipitation ; Medical sciences ; Mice ; Mice, Transgenic ; nerve growth factor ; Nerve Growth Factor - antagonists &amp; inhibitors ; Nerve Growth Factor - pharmacology ; Neurology ; Neurons - drug effects ; Neurons - pathology ; NF-kappa B - metabolism ; NF-κB ; Organic mental disorders. Neuropsychology ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Signal Transduction - drug effects ; Transfection - methods ; Vesicular Inhibitory Amino Acid Transport Proteins - metabolism</subject><ispartof>Journal of neurochemistry, 2009-12, Vol.111 (6), p.1425-1433</ispartof><rights>2009 The Authors. Journal Compilation © 2009 International Society for Neurochemistry</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4222-70f34470c0166a98dc58189dbffc9997dc7a88af3d50f9cff21734d39535f2e33</citedby><cites>FETCH-LOGICAL-c4222-70f34470c0166a98dc58189dbffc9997dc7a88af3d50f9cff21734d39535f2e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22184238$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20050289$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arevalo, Maria-Ángeles</creatorcontrib><creatorcontrib>Roldan, Pedro M</creatorcontrib><creatorcontrib>Chacón, Pedro J</creatorcontrib><creatorcontrib>Rodríguez-Tebar, Alfredo</creatorcontrib><title>Amyloid β serves as an NGF-like neurotrophic factor or acts as a NGF antagonist depending on its concentration</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>In the nervous system, both the shape and connectivity of neurons are strongly influenced by soluble, extracellular factors. Indeed, we recently demonstrated that after binding to p75NTR, the common neurotrophin receptor, nerve growth factor (NGF) controls the morphology and connectivity of cultured mouse hippocampal neurons by encouraging the production of fewer yet longer dendrites, and by augmenting GABAergic connectivity. These effects of NGF are mediated by the differential expression of Enhancer-of-split 1/5 homologs and neurogenin 3. Amyloid β (Aβ), a pathogenic agent in Alzheimer's disease (AD) is known to bind to p75NTR, hence we studied its influence on cultured hippocampal neurons. At 800 nM, Aβ(1-40) prevents NGF-induced activation of NF-κB and consequently, it depresses the expression of Enhancer-of-split 1. Thus, at this concentration, the effect of Aβ on neurons is antagonistic to those provoked by NGF and accordingly, neurons sprout more yet shorter dendrites and their GABAergic input decreases. In contrast, at lower concentration, 20 nM, the amyloid induces cellular effects similar to those induced by NGF, both in terms of gene expression, neuronal morphology, and GABAergic connectivity. Our results demonstrate that Aβ may act as a neurotrophic factor that mimics the activity of NGF. However, at higher concentrations, the amyloid behaves as an antagonist of NGF, contributing to the advent of AD.</description><subject>Adult and adolescent clinical studies</subject><subject>amyloid</subject><subject>Amyloid beta-Peptides - pharmacology</subject><subject>Amyloid β</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>dendrite morphology</subject><subject>Dendrites - drug effects</subject><subject>Dendrites - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Embryo, Mammalian</subject><subject>Enhancer-of-split</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>GABAergic synapses</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Green Fluorescent Proteins - genetics</subject><subject>Hippocampus - cytology</subject><subject>I-kappa B Proteins - metabolism</subject><subject>Immunoprecipitation</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>nerve growth factor</subject><subject>Nerve Growth Factor - antagonists &amp; inhibitors</subject><subject>Nerve Growth Factor - pharmacology</subject><subject>Neurology</subject><subject>Neurons - drug effects</subject><subject>Neurons - pathology</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB</subject><subject>Organic mental disorders. Neuropsychology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Signal Transduction - drug effects</subject><subject>Transfection - methods</subject><subject>Vesicular Inhibitory Amino Acid Transport Proteins - metabolism</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNkMtuEzEUhi0EoqHwCuANYjXD8WUy9oJFFdHSqioL6NpyfQkOEzvYE2heiwfhmfAwoWyxjuQj-ft8jn6EMIGW1PN20xLek4aTTrYUQLaw5IS294_Q4uHhMVoAUNow4PQEPStlA0CWfEmeopPqdECFXKB0tj0MKVj86ycuLn93BetaEd9cnDdD-OpwdPucxpx2X4LBXpsxZVyrNjM6kVUY9TrFUEZs3c5FG-Iap4hDhUyKxsUx6zGk-Bw98Xoo7sXxPkW35-8_rz401x8vLldn143htC7dg2ec92DqyksthTWdIELaO--NlLK3ptdCaM9sB14a7ynpGbdMdqzz1DF2it7M_-5y-rZ3ZVTbUIwbBh1d2hdVaUqBd10lxUyanErJzqtdDludD4qAmtJWGzWFqqZQ1ZS2-pO2uq_qy-OQ_d3W2Qfxb7wVeH0EdDF68FlHE8o_jhLBKROVezdzP8LgDv-9gLq6WU1d9V_NvtdJ6XWuM24_USAMSA89E5T9BtrDpCk</recordid><startdate>200912</startdate><enddate>200912</enddate><creator>Arevalo, Maria-Ángeles</creator><creator>Roldan, Pedro M</creator><creator>Chacón, Pedro J</creator><creator>Rodríguez-Tebar, Alfredo</creator><general>Oxford, UK : Blackwell Publishing Ltd</general><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200912</creationdate><title>Amyloid β serves as an NGF-like neurotrophic factor or acts as a NGF antagonist depending on its concentration</title><author>Arevalo, Maria-Ángeles ; Roldan, Pedro M ; Chacón, Pedro J ; Rodríguez-Tebar, Alfredo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4222-70f34470c0166a98dc58189dbffc9997dc7a88af3d50f9cff21734d39535f2e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult and adolescent clinical studies</topic><topic>amyloid</topic><topic>Amyloid beta-Peptides - pharmacology</topic><topic>Amyloid β</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>dendrite morphology</topic><topic>Dendrites - drug effects</topic><topic>Dendrites - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Embryo, Mammalian</topic><topic>Enhancer-of-split</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>GABAergic synapses</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Green Fluorescent Proteins - genetics</topic><topic>Hippocampus - cytology</topic><topic>I-kappa B Proteins - metabolism</topic><topic>Immunoprecipitation</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>nerve growth factor</topic><topic>Nerve Growth Factor - antagonists &amp; inhibitors</topic><topic>Nerve Growth Factor - pharmacology</topic><topic>Neurology</topic><topic>Neurons - drug effects</topic><topic>Neurons - pathology</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB</topic><topic>Organic mental disorders. Neuropsychology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Signal Transduction - drug effects</topic><topic>Transfection - methods</topic><topic>Vesicular Inhibitory Amino Acid Transport Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arevalo, Maria-Ángeles</creatorcontrib><creatorcontrib>Roldan, Pedro M</creatorcontrib><creatorcontrib>Chacón, Pedro J</creatorcontrib><creatorcontrib>Rodríguez-Tebar, Alfredo</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arevalo, Maria-Ángeles</au><au>Roldan, Pedro M</au><au>Chacón, Pedro J</au><au>Rodríguez-Tebar, Alfredo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amyloid β serves as an NGF-like neurotrophic factor or acts as a NGF antagonist depending on its concentration</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>2009-12</date><risdate>2009</risdate><volume>111</volume><issue>6</issue><spage>1425</spage><epage>1433</epage><pages>1425-1433</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>In the nervous system, both the shape and connectivity of neurons are strongly influenced by soluble, extracellular factors. Indeed, we recently demonstrated that after binding to p75NTR, the common neurotrophin receptor, nerve growth factor (NGF) controls the morphology and connectivity of cultured mouse hippocampal neurons by encouraging the production of fewer yet longer dendrites, and by augmenting GABAergic connectivity. These effects of NGF are mediated by the differential expression of Enhancer-of-split 1/5 homologs and neurogenin 3. Amyloid β (Aβ), a pathogenic agent in Alzheimer's disease (AD) is known to bind to p75NTR, hence we studied its influence on cultured hippocampal neurons. At 800 nM, Aβ(1-40) prevents NGF-induced activation of NF-κB and consequently, it depresses the expression of Enhancer-of-split 1. Thus, at this concentration, the effect of Aβ on neurons is antagonistic to those provoked by NGF and accordingly, neurons sprout more yet shorter dendrites and their GABAergic input decreases. In contrast, at lower concentration, 20 nM, the amyloid induces cellular effects similar to those induced by NGF, both in terms of gene expression, neuronal morphology, and GABAergic connectivity. Our results demonstrate that Aβ may act as a neurotrophic factor that mimics the activity of NGF. However, at higher concentrations, the amyloid behaves as an antagonist of NGF, contributing to the advent of AD.</abstract><cop>Oxford, UK</cop><pub>Oxford, UK : Blackwell Publishing Ltd</pub><pmid>20050289</pmid><doi>10.1111/j.1471-4159.2009.06412.x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 2009-12, Vol.111 (6), p.1425-1433
issn 0022-3042
1471-4159
language eng
recordid cdi_proquest_miscellaneous_734220455
source Wiley-Blackwell Read & Publish Collection; Free Full-Text Journals in Chemistry
subjects Adult and adolescent clinical studies
amyloid
Amyloid beta-Peptides - pharmacology
Amyloid β
Animals
Biological and medical sciences
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
dendrite morphology
Dendrites - drug effects
Dendrites - metabolism
Dose-Response Relationship, Drug
Embryo, Mammalian
Enhancer-of-split
Enzyme-Linked Immunosorbent Assay - methods
GABAergic synapses
Gene Expression Regulation - drug effects
Green Fluorescent Proteins - genetics
Hippocampus - cytology
I-kappa B Proteins - metabolism
Immunoprecipitation
Medical sciences
Mice
Mice, Transgenic
nerve growth factor
Nerve Growth Factor - antagonists & inhibitors
Nerve Growth Factor - pharmacology
Neurology
Neurons - drug effects
Neurons - pathology
NF-kappa B - metabolism
NF-κB
Organic mental disorders. Neuropsychology
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Signal Transduction - drug effects
Transfection - methods
Vesicular Inhibitory Amino Acid Transport Proteins - metabolism
title Amyloid β serves as an NGF-like neurotrophic factor or acts as a NGF antagonist depending on its concentration
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T09%3A51%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amyloid%20%CE%B2%20serves%20as%20an%20NGF-like%20neurotrophic%20factor%20or%20acts%20as%20a%20NGF%20antagonist%20depending%20on%20its%20concentration&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Arevalo,%20Maria-%C3%81ngeles&rft.date=2009-12&rft.volume=111&rft.issue=6&rft.spage=1425&rft.epage=1433&rft.pages=1425-1433&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1111/j.1471-4159.2009.06412.x&rft_dat=%3Cproquest_cross%3E734220455%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4222-70f34470c0166a98dc58189dbffc9997dc7a88af3d50f9cff21734d39535f2e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734220455&rft_id=info:pmid/20050289&rfr_iscdi=true